Coronavirus disease 2019 (COVID-19), human erythrocytes and the PKC-alpha/-beta inhibitor chelerythrine –possible therapeutic implication

References

• Scheeren FA, Nagasawa M, Weijer K, et al. T cell-independent development and induction of somatic hypermutation in human IgM+ IgD+ CD27+ B cells. J Exp Med. 2008;205:2033–2042.
   PubMed Web of Science ®Google Scholar
• Klein U, Goossens T, Fischer M, et al. Somatic hypermutation in normal and transformed human B cells. Immunol Rev. 1998;162:261–280.
   PubMed Web of Science ®Google Scholar
• Li Z, Woo CJ, Iglesias-Ussel MD, et al. The generation of antibody diversity through somatic hypermutation and class switch recombination. Genes Dev. 2004;18:1–11.
   PubMed Web of Science ®Google Scholar
• Lee GS, Brandt VL, Roth DB. B cell development leads off with a base hit: dU:dG mismatches in class switching and hypermutation. Mol Cell. 2004;16:505–508.
   PubMed Web of Science ®Google Scholar
• Steinhauer DA, Holland JJ. Rapid evolution of RNA viruses. Annu Rev Microbiol. 1987;41:409–433.
   PubMed Web of Science ®Google Scholar
• Kim D, Lee JY, Yang JS, et al. The architecture of SARS-CoV-2 transcriptome. Cell. 2020;181:914–21 e10.
   PubMed Web of Science ®Google Scholar
• Solinas C, Perra L, Aiello M, et al. A critical evaluation of glucocorticoids in the management of severe COVID-19. Cytokine Growth Factor Rev. 2020;54:8–23.
   PubMed Web of Science ®Google Scholar
• Ferner RE, Aronson JK. Chloroquine and hydroxychloroquine in covid-19. BMJ. 2020;369:m1432.
   PubMedGoogle Scholar
• Bonsch C, Kempf C, Mueller I, et al. Chloroquine and its derivatives exacerbate B19V-associated anemia by promoting viral replication. PLoS Negl Trop Dis. 2010;4:e669.
   PubMed Web of Science ®Google Scholar
• Theoharides TC, Conti P. Dexamethasone for COVID-19? Not so fast. J Biol Regul Homeost Agents. 2020;34:1241-1243.
   Web of Science ®Google Scholar
• Paccaud JP, Carpentier JL, Schifferli JA. Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: effect on immune adherence. Eur J Immunol. 1990;20:283–289.
   PubMed Web of Science ®Google Scholar
• Craig ML, Bankovich AJ, Taylor RP. Visualization of the transfer reaction: tracking immune complexes from erythrocyte complement receptor 1 to macrophages. Clin Immunol. 2002;105:36–47.
   PubMed Web of Science ®Google Scholar
• Hanel P, Andreani P, Graler MH. Erythrocytes store and release sphingosine 1-phosphate in blood. Faseb J. 2007;21:1202–1209.
   PubMed Web of Science ®Google Scholar
• Matloubian M, Lo CG, Cinamon G, et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature. 2004;427:355–360.
   PubMed Web of Science ®Google Scholar
• Garcia JG, Liu F, Verin AD, et al. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest. 2001;108:689–701.
   PubMed Web of Science ®Google Scholar
• Jo SK, Bajwa A, Awad AS, et al. Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease. Kidney Int. 2008;73:1220–1230.
   PubMed Web of Science ®Google Scholar
• Schwalm S, Pfeilschifter J, Huwiler A. Targeting the sphingosine kinase/sphingosine 1-phosphate pathway to treat chronic inflammatory kidney diseases. Basic Clin Pharmacol Toxicol. 2014;114:44–49.
   PubMed Web of Science ®Google Scholar
• Hu Y, Li M, Gothert JR, et al. Hemovascular progenitors in the kidney require sphingosine-1-phosphate receptor 1 for vascular development. J Am Soc Nephrol. 2016;27:1984–1995.
   PubMed Web of Science ®Google Scholar
• Wissbrock A, Goradia NB, Kumar A, et al. Structural insights into heme binding to IL-36alpha proinflammatory cytokine. Sci Rep. 2019;9:16893.
   PubMed Web of Science ®Google Scholar
• Igarashi J, Murase M, Iizuka A, et al. Elucidation of the heme binding site of heme-regulated eukaryotic initiation factor 2alpha kinase and the role of the regulatory motif in heme sensing by spectroscopic and catalytic studies of mutant proteins. J Biol Chem. 2008;283:18782–18791.
   PubMed Web of Science ®Google Scholar
• Schakel K, von Kietzell M, Hansel A, et al. Human 6-sulfo LacNAc-expressing dendritic cells are principal producers of early interleukin-12 and are controlled by erythrocytes. Immunity. 2006;24:767–777.
   PubMed Web of Science ®Google Scholar
• Horuk R, Colby TJ, Darbonne WC, et al. The human erythrocyte inflammatory peptide (chemokine) receptor. Biochemical characterization, solubilization, and development of a binding assay for the soluble receptor. Biochemistry. 1993;32:5733–5738.
   PubMed Web of Science ®Google Scholar
• de Winter RJ, Manten A, de Jong YP, et al. Interleukin 8 released after acute myocardial infarction is mainly bound to erythrocytes. Heart. 1997;78:598–602.
   PubMed Web of Science ®Google Scholar
• Ragab D, Salah Eldin H, Taeimah M, et al. The COVID-19 cytokine storm; what we know so far. Front Immunol. 2020;11:1446.
   PubMed Web of Science ®Google Scholar
• Maharaj NP, Wies E, Stoll A, et al. Conventional protein kinase C-alpha (PKC-alpha) and PKC-beta negatively regulate RIG-I antiviral signal transduction. J Virol. 2012;86:1358–1371.
   PubMed Web of Science ®Google Scholar
• Chen F, Kumar S, Yu Y, et al. PKC-dependent phosphorylation of eNOS at T495 regulates eNOS coupling and endothelial barrier function in response to G+ -toxins. PLoS One. 2014;9:e99823.
   PubMed Web of Science ®Google Scholar
• Marjuki H, Alam MI, Ehrhardt C, et al. Membrane accumulation of influenza A virus hemagglutinin triggers nuclear export of the viral genome via protein kinase Calpha-mediated activation of ERK signaling. J Biol Chem. 2006;281:16707–16715.
   PubMed Web of Science ®Google Scholar
• Rossman JS, Lamb RA. Influenza virus assembly and budding. Virology. 2011;411:229–236.
   PubMed Web of Science ®Google Scholar
• Tooze J, Tooze S, Warren G. Replication of coronavirus MHV-A59 in sac- cells: determination of the first site of budding of progeny virions. Eur J Cell Biol. 1984;33:281–293.
   PubMed Web of Science ®Google Scholar
• Wu KE, Fazal FM, Parker KR, et al. RNA-GPS predicts SARS-CoV-2 RNA residency to host mitochondria and nucleolus. Cell Syst. 2020;11:102–8 e3.
   PubMed Web of Science ®Google Scholar
• Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 transmission and pathogenesis. Trends Immunol. 2020;41(12):1100–1115.
   PubMed Web of Science ®Google Scholar
• Xia H, Cao Z, Xie X, et al. Evasion of type I interferon by SARS-CoV-2. Cell Rep. 2020;33:108234.
   PubMed Web of Science ®Google Scholar
• Herbert JM, Augereau JM, Gleye J, et al. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 1990;172:993–999.
   PubMed Web of Science ®Google Scholar
• Andrews DA, Yang L, Low PS. Phorbol ester stimulates a protein kinase C-mediated agatoxin-TK-sensitive calcium permeability pathway in human red blood cells. Blood. 2002;100:3392–3399.
   PubMed Web of Science ®Google Scholar
• Chmura SJ, Dolan ME, Cha A, et al. In vitro and in vivo activity of protein kinase C inhibitor chelerythrine chloride induces tumor cell toxicity and growth delay in vivo. Clin Cancer Res. 2000;6:737–742.
   PubMed Web of Science ®Google Scholar
• Shi B, Li S, Ju H, et al. Protein kinase C inhibitor chelerythrine attenuates partial unilateral ureteral obstruction induced kidney injury in neonatal rats. Life Sci. 2019;216:85–91.
   PubMed Web of Science ®Google Scholar
• Ghashghaeinia M, Koralkova P, Giustarini D, et al. The specific PKC-alpha inhibitor chelerythrine blunts costunolide-induced eryptosis. Apoptosis. 2020;25:674–685.
   PubMed Web of Science ®Google Scholar
• Jarvis WD, Turner AJ, Povirk LF, et al. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res. 1994;54:1707–1714.
   PubMed Web of Science ®Google Scholar
• Wan KF, Chan SL, Sukumaran SK, et al. Chelerythrine induces apoptosis through a Bax/Bak-independent mitochondrial mechanism. J Biol Chem. 2008;283:8423–8433.
   PubMed Web of Science ®Google Scholar
• Allam M, Bertrand R, Zhang-Sun G, et al. Cholera toxin triggers apoptosis in human lung cancer cell lines. Cancer Res. 1997;57:2615–2618.
   PubMed Web of Science ®Google Scholar
• Parlakpinar H, Tasdemir S, Polat A, et al. Protective effect of chelerythrine on gentamicin-induced nephrotoxicity. Cell Biochem Funct. 2006;24:41–48.
   PubMed Web of Science ®Google Scholar
• He N, Wang P, Wang P, et al. Antibacterial mechanism of chelerythrine isolated from root of Toddalia asiatica (Linn) Lam. BMC Complement Altern Med. 2018;18:261.
   PubMed Web of Science ®Google Scholar
• Li J, Li B, Wu Y, et al. Luminescence and binding properties of two isoquinoline alkaloids chelerythrine and sanguinarine with ctDNA. Spectrochim Acta A Mol Biomol Spectrosc. 2012;95:80–85.
   PubMed Web of Science ®Google Scholar
• Bai LP, Hagihara M, Nakatani K, et al. Recognition of chelerythrine to human telomeric DNA and RNA G-quadruplexes. Sci Rep. 2014;4:6767.
   PubMed Web of Science ®Google Scholar
• Bai LP, Zhao ZZ, Cai Z, et al. Site-specific binding of chelerythrine to single cytosine and thymine bulges in DNA hairpins. Nucleic Acids Symp Ser (Oxf). 2006;50:197–198.
   Google Scholar
• Terenzi A, Gattuso H, Spinello A, et al. Targeting G-quadruplexes with organic dyes: chelerythrine-DNA binding elucidated by combining molecular modeling and optical spectroscopy. Antioxidants (Basel). 2019;8:472.
   Google Scholar
• Jana J, Mondal S, Bhattacharjee P, et al. Chelerythrine down regulates expression of VEGFA, BCL2 and KRAS by arresting G-Quadruplex structures at their promoter regions. Sci Rep. 2017;7:40706.
   PubMed Web of Science ®Google Scholar
• Basu P, Payghan PV, Ghoshal N, et al. Structural and thermodynamic analysis of the binding of tRNA(phe) by the putative anticancer alkaloid chelerythrine: spectroscopy, calorimetry and molecular docking studies. J Photochem Photobiol B. 2016;161:335–344.
   PubMed Web of Science ®Google Scholar
• Agarwala P, Pandey S, Maiti S. The tale of RNA G-quadruplex. Org Biomol Chem. 2015;13:5570–5585.
   PubMed Web of Science ®Google Scholar
• Hognon C, Miclot T, Garci AIC, et al. Role of RNA guanine quadruplexes in favoring the dimerization of SARS unique domain in coronaviruses. J Phys Chem Lett. 2020;11:5661–5667.
   PubMed Web of Science ®Google Scholar
• Kato H, Takeuchi O, Mikamo-Satoh E, et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med. 2008;205:1601–1610.
   PubMed Web of Science ®Google Scholar
• Pichlmair A, Schulz O, Tan CP, et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5ʹ-phosphates. Science. 2006;314:997–1001.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Kim JH, Kim YG, et al. Protein kinase C-related kinase 2 regulates hepatitis C virus RNA polymerase function by phosphorylation. J Biol Chem. 2004;279:50031–50041.
   PubMed Web of Science ®Google Scholar
• Fonseca AM, Pereira CF, Porto G, et al. Red blood cells promote survival and cell cycle progression of human peripheral blood T cells independently of CD58/LFA-3 and heme compounds. Cell Immunol. 2003;224:17–28.
   PubMed Web of Science ®Google Scholar
• Porto B, Fonseca AM, Godinho I, et al. Human red blood cells have an enhancing effect on the relative expansion of CD8+ T lymphocytes in vitro. Cell Prolif. 2001;34:359–367.
   PubMed Web of Science ®Google Scholar
• Beck Z, Brown BK, Wieczorek L, et al. Human erythrocytes selectively bind and enrich infectious HIV-1 virions. PLoS One. 2009;4:e8297.
   PubMed Web of Science ®Google Scholar
• Morera D, MacKenzie SA. Is there a direct role for erythrocytes in the immune response? Vet Res. 2011;42:89.
   PubMed Web of Science ®Google Scholar
• Umeda M, Nojima S, Inoue K. Activity of human erythrocyte gangliosides as a receptor to HVJ. Virology. 1984;133:172–182.
   PubMed Web of Science ®Google Scholar
• Paul RW, Lee PW. Glycophorin is the reovirus receptor on human erythrocytes. Virology. 1987;159:94–101.
   PubMed Web of Science ®Google Scholar
• Enegren BJ, Burness AT. Chemical structure of attachment sites for viruses on human erythrocytes. Nature. 1977;268:536–537.
   PubMed Web of Science ®Google Scholar
• Eaton BT, Crameri GS. The site of bluetongue virus attachment to glycophorins from a number of animal erythrocytes. J Gen Virol. 1989;70(Pt 12):3347–3353.
   PubMedGoogle Scholar
• Nishimura H, Sugawara K, Kitame F, et al. Attachment of influenza C virus to human erythrocytes. J Gen Virol. 1988;69(Pt 10):2545–2553.
   PubMedGoogle Scholar
• Ruvoen-Clouet N, Blanchard D, Andre-Fontaine G, et al. Partial characterization of the human erythrocyte receptor for rabbit haemorrhagic disease virus. Res Virol. 1995;146:33–41.
   PubMedGoogle Scholar
• Costafreda MI, Ribes E, Franch A, et al. A single mutation in the glycophorin A binding site of hepatitis A virus enhances virus clearance from the blood and results in a lower fitness variant. J Virol. 2012;86:7887–7895.
   PubMed Web of Science ®Google Scholar
• Angel MA, Burness AT. The attachment of encephalomyocarditis virus to erythrocytes from several animal species. Virology. 1977;83:428–432.
   PubMed Web of Science ®Google Scholar
• Allaway GP, Burness AT. Site of attachment of encephalomyocarditis virus on human erythrocytes. J Virol. 1986;59:768–770.
   PubMed Web of Science ®Google Scholar
• Li J, Wang JP, Ghiran I, et al. Complement receptor 1 expression on mouse erythrocytes mediates clearance of Streptococcus pneumoniae by immune adherence. Infect Immun. 2010;78:3129–3135.
   PubMed Web of Science ®Google Scholar
• Thielen AJF, Zeerleder S, Wouters D. Consequences of dysregulated complement regulators on red blood cells. Blood Rev. 2018;32:280–288.
   PubMed Web of Science ®Google Scholar
• Carlisle RC, Di Y, Cerny AM, et al. Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1. Blood. 2009;113:1909–1918.
   PubMed Web of Science ®Google Scholar
• Miyaike J, Iwasaki Y, Takahashi A, et al. Regulation of circulating immune complexes by complement receptor type 1 on erythrocytes in chronic viral liver diseases. Gut. 2002;51:591–596.
   PubMed Web of Science ®Google Scholar
• Wong CH, Jenne CN, Petri B, et al. Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance. Nat Immunol. 2013;14:785–792.
   PubMed Web of Science ®Google Scholar
• Broadley SP, Plaumann A, Coletti R, et al. Dual-track clearance of circulating bacteria balances rapid restoration of blood sterility with induction of adaptive immunity. Cell Host Microbe. 2016;20:36–48.
   PubMed Web of Science ®Google Scholar
• Llorente C, Schnabl B. Fast-track clearance of bacteria from the liver. Cell Host Microbe. 2016;20:1–2.
   PubMed Web of Science ®Google Scholar
• Medina-Jover F, Gendrau-Sanclemente N, Vinals F. SGK1 is a signalling hub that controls protein synthesis and proliferation in endothelial cells. FEBS Lett. 2020;594:3200–3215.
   PubMed Web of Science ®Google Scholar
• Partovian C, Ju R, Zhuang ZW, et al. Syndecan-4 regulates subcellular localization of mTOR Complex2 and Akt activation in a PKCalpha-dependent manner in endothelial cells. Mol Cell. 2008;32:140–149.
   PubMed Web of Science ®Google Scholar
• Downward J. How BAD phosphorylation is good for survival. Nat Cell Biol. 1999;1:E33–5.
   PubMed Web of Science ®Google Scholar
• Slaninova I, Slanina J, Taborska E. Quaternary benzo[c]phenanthridine alkaloids–novel cell permeant and red fluorescing DNA probes. Cytometry A. 2007;71:700–708.
   PubMedGoogle Scholar
• Dorney KM, Sizemore IE, Alqahtani T, et al. Surface-enhanced Raman spectroscopy (SERS) tracking of chelerythrine, a Na(+)/K(+) pump inhibitor, into cytosol and plasma membrane fractions of human lens epithelial cell cultures. Cell Physiol Biochem. 2013;32:146–156.
   PubMedGoogle Scholar
• Cheng T. Remedy for anemia and arthritis. Patent U, ed. 1986.
   Google Scholar